15th Annual Coastal Dermatology Seminar

Thursday, October 3, 2019, 6:45 AM - Saturday, October 5, 2019, 12:00 PM, Motif Hotel Seattle, 1415 5th Ave

AMA PRA Category 1 Credits™ (14.25 hours), AMA PRA Category 1 Credits™ Designated (14.25 hours)


The Coastal Dermatology Symposium, presented annually since 2005, and designed to provide high-quality continuing medical education featuring latest updates in medical dermatology and the diagnosis and treatment of various dermatological conditions. The educational content is of interest to practicing dermatologists, dermatology residents, internists, family practitioners, physician assistants, nurse practitioners, nurses and other healthcare professionals who treat diseases of the skin. For the 15th Annual Coastal Dermatology Symposium, an internationally known faculty and key thought leaders will present in-depth education and stimulate audience discussion on topics including Acne, Rosacea, Contact Dermatitis, Atopic Dermatitis, Pediatric Dermatology, Skin Cancer, Psoriasis, Sunscreens, Eczema, and Dermoscopy.

To register, please go to: 

https://www.globalacademycme.com/conferences/15th-annual-coastal-dermatology-symposium/welcome-15th-annual-coastal-dermatology-symposium

FEES (Go to website for full details):

Until 6/17/19	Until 7/22/19	Until 8/30/19	After 8/30/19	Onsite Registration
Physicians	$495	$595	$695	$795	$895
NP/PA/Nurses/Pharmacists	$445	$545	$595	$695	$795
Residents/Fellows	$225	$250	$300	$300	$300
Industry (Not Exhibiting)	$895	$995	$1500	$1995	$1995
Spouse/Guest (Welcome Reception Only)*	$65	$65	$65	$65	$65

1. Design a comprehensive treatment plan for acne patients based on clinical guidelines, incorporating pharmacologic and nonpharmacologic strategies.
2. Discuss the clinical relevance of the most recent research on the etiologies and therapy of acne vulgaris.
3. Identify risk factors for actinic keratosis.
4. Design individualized treatment strategies for patients with actinic keratosis to reduce risk of squamous cell carcinoma.
5. Design evidence-based, guideline-driven treatment strategies for patients with AD based on disease severity with the goal of clear or almost clear skin.
6. Incorporate strategies for use of use of new therapies aimed at blocking the inflammatory mediators of AD.
7. Identify medication-induced auto-immunities, including autoimmune vasculitis syndromes, connective tissue diseases, and blistering diseases.
8. Assess and manage eczematous dermatitis in the context of primary immunodeficiencies in children and adults.
9. Describe evidence-based strategies for the diagnosis and pharmacologic management of hyperhidrosis.
10. Develop screening strategies to identify comorbid conditions in pediatric patients with dermatologic issues.
11. Design psychologic and medical treatment strategies appropriate for pediatric patients with common dermatologic conditions.
12. Discuss photo-protection with patients, including pediatric patients and their caregivers.
13. Describe the algorithm for the diagnosis of photodermatoses.
14. Describe the pathophysiology of psoriasis and its associated comorbidities.
15. Diagnose and treat patients with psoriasis appropriately, based on current clinical guidelines.
16. Design treatment strategies that incorporate of biologic therapies in the management of appropriately selected patients with psoriasis.
17. Increase routine screening for psoriatic arthritis in patients with psoriasis
18. Develop strategies to increase screening for and management of comorbidities of psoriasis, including cardiovascular and psychiatric disorders.
19. Identify key patient characteristics to individualize treatment selection in patients with psoriasis.
20. Recognize clinical presentations of rheumatic skin disease, including conditions that mimic these diseases.

This Activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati, Global Academy for Medical Education and Postgraduate Institute for Medicine.

The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Cincinnati designates this live activity for a maximum of 13.5 AMA PRA Category 1 Credits™.  Physicians should claim only the credits commensurate with the extent of their participation in the activity.

 

The opinions expressed during the live activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees’ professional development.

No faculty are available for this activity at this time.